Skip to content
CompanySight
Sign in
Company No. 10152652 · Incorporated 28 Apr 2016

Advanz Pharma Europe Limited

Registered name: ADVANZ PHARMA EUROPE LIMITED

Part of Mercury Pharma Group Limited group

Advanz Pharma Europe Limited does not publish its revenue or profit. Its accounts to 31 Dec 2023 show net assets of £2.

Advanz Pharma Europe Limited did not publish its revenue or profit — small companies aren’t required to file a profit & loss account. Its accounts for the year to 31 Dec 2023 showed net assets of £2 and 0 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in London; we hold 2 years of its filed accounts.

Balance sheet onlySection G · Wholesale and retail trade; repair of motor vehiclesSIC 46460Wholesale of pharmaceutical goods
Status
Active
Location
London, London
Age
10 yrs · since 2016
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2023

Key figures

Small team

Revenue not disclosed

Advanz Pharma Europe Limited’s accounts for the year to 31 Dec 2023 contain a balance sheet but no profit & loss account, so its revenue and profit are not public. UK small and micro-entity companies are not required to publish a P&L — this is normal and says nothing about how the business is performing.

We never estimate revenue. Below you’ll find the balance-sheet figures that were filed — useful as indirect signals of momentum, but they are not revenue or profit.

Employees
0
Net assets
£2

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

2 filed years

Financial history

Multi-year financials, oldest to newest
Year to31 Dec 202231 Dec 2023
DisclosureNo P&LNo P&L
Profit & loss
Revenue (turnover)——
Profit (best available)——
Employees (average)00
Ratios
Profit margin——
Balance sheet — indirect signals, not revenue
Net assets£2£2
Fixed assets£0£0
Current assets£378k£2
SourceFullAccounts · bulk data Sep 2024FullAccounts · bulk data Sep 2024
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
0%
Now £2
Cash at bank
—
Now —
Headcount
—
Now 0
Deferred income
—
Now —
Fixed assets
—
Now £0
Corporate ownership

Group structure

Ownership chain

  1. Mercury Pharma Group Limitedultimate parent75–100%
  2. Advanz Pharma Europe Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (8)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2023, from the Companies House accounts bulk data published Sep 2024. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.